Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 1 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 8754225

    Process for preparing a biphenyl-2-ylcarbamic acid

    Theravance, Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  2. US 8754223

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  3. US 8735625

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted May 27, 2014 · Expires May 22, 2034

    granted

  4. US 8729119

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted May 20, 2014 · Expires May 15, 2034

    granted

  5. US 8716313

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted May 6, 2014 · Expires May 1, 2034

    granted

  6. US 8703791

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  7. US 8697724

    Crystalline oxalate salts of a diamide compound

    Theravance, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  8. US 8691868

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  9. US 8686184

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  10. US 8664254

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  11. US 8664242

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  12. US 8664227

    Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

    Theravance, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  13. US 8658671

    Crystalline form of a quinolinone-carboxamide compound

    Theravance, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  14. US 8658691

    Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

    Theravance, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  15. US 8637676

    Dual-acting benzoimidazole antihypertensive agents

    Theravance, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  16. US 8637568

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  17. US 8618131

    Biphenyl derivatives

    Theravance, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  18. US 8604058

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  19. US 8598170

    Dual-acting oxazole antihypertensive agents

    Theravance, Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  20. US 8592453

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  21. US 8592596

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  22. US 8586536

    Neprilysin inhibitors

    Theravance, Inc. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted

  23. US 8575192

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  24. US 8569351

    Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity

    Theravance, Inc. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.